Learning to Say Goodbye | NEJM
A pediatrician caring for patients with a rare and life-limiting disease learns from his mentor the benefits of acknowledging that his story and his patients’ stories are inextricably intertwined.
A pediatrician caring for patients with a rare and life-limiting disease learns from his mentor the benefits of acknowledging that his story and his patients’ stories are inextricably intertwined.
29 seconds · Clipped by Hari Krishnan · Original video “The Galton Board” by D!NG
Childhood BMI nearly as important as adult BMI
Pediatric Hospital Medicine: A High-Value Approach
Bortezomib, lenalidomide, and dexamethasone (VRd) is a preferred first-line treatment option for patients with newly diagnosed multiple myeloma. Whether the addition of the anti-CD38 monoclonal…
Dengue cases globally are the highest on record this year. Cases in the Americas are more than double all last year.
Learn more about strategies and approaches schools can use to improve students’ mental health.
Diabetologia – Given the proven benefits of screening to reduce diabetic ketoacidosis (DKA) likelihood at the time of stage 3 type 1 diabetes diagnosis, and…
A new CMS place-of-service code supports the treatment of people experiencing unsheltered homelessness. Health systems, payers, and policymakers could take additional steps to bolster street…
For decades, scientists believed that only male birds sang. Then women entered the field and showed what their predecessors had missed.
Immune thrombocytopenia (ITP) is an autoimmune disease characterized by autoantibody-mediated platelet destruction. Treatment with CM313, a novel anti-CD38 monoclonal antibody, can result in target…